Effect of Acalypha wilkesiana Muell Arg on plasma sodium and potassium concentration of normal rabbits

Pakistan Journal of Nutrition

Volumn 7, Issue 1, 2008, Pages 130-132

  Ikewuchi, Jude Chigozie ^a   Anyadiegwu, Amaka ^b   Ugono, Erhieyovwe Yovwe ^a   Okungbowa, Solomon Osas ^a  

^a BENSON IDAHOSA UNIVERSITY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Acalypha wilkesiana; Hypertension; Potassium sparing diuretic

Indexed keywords

ACALYPHA WILKESIANA EXTRACT; PLANT EXTRACT; POTASSIUM; SODIUM; UNCLASSIFIED DRUG;

ACALYPHA WILKESIANA; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; DRUG SOLUTION; EUPHORBIA; HYPERTENSION; NONHUMAN; PLANT LEAF; POTASSIUM BLOOD LEVEL; RABBIT; SODIUM BLOOD LEVEL;

ACALYPHA WILKESIANA; ORYCTOLAGUS CUNICULUS;

EID: 37549046017     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2008.130.132     Document Type: Article

References (18)

1. Adesina, S.K., O. Idowu, A.O. Ogundaini, H. Oladimeji, T.A. Olugbade, G.O. Onawunmi and M. Pais, 2000. Antimicrobial constituents of the leaves of Acalypha wilkesiana and Acalypha hispida. Phytotherapy Res., 14: 371-374.
2. Akinde, B.E., 1986. Phytochemical and Microbiological Evaluation of the oils from the Leaves of Acalypha wilkesiana. In: Sofowora A, editor. The State of Medicinal Plant Research in Nigeria. University of Ibadan Press, Nigeria, pp: 362-363.
3. Alade, P.I. and O.N. Irobi, 1993. Antimicrobial activities of crude leaf extracts of Acalypha wilkesiana. J. Ethnopharmacol., 39: 171-174.
4. Brater, D.C., 1998. Diuretic Therapy. N. Engl. J. Med., 333: 387-395.
5. Burton, D.R. and W.P. Theodore, 2007. Mechanism of action of diuretics. UpToDate, pp: 15.1. http://patients.uptodate.com/topic.asp?file=fldlytes/ 25960. (accessed July, 2007).
6. Coruzzi, P., L. Brambilla, V. Brambilla, M. Gualerzi, M. Rossi, G. Parati, M. Di Rienzo, J. Tadonio and A. Novarini, 2001. Potassium Depletion and Salt Sensitivity in Essential Hypertension. J. Clin. Endocrinol. Metabol., 86: 2857-2862.
7. Crook, M.A., 2006. Clinical Chemistry and Metabolic Medicine. 7th Edn. Hodder Arnold, London, pp: 84.
8. Dmitrieva, R.I. and P.A. Doris, 2002. Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function. Exptl. Biol. Med., 227: 561-569.
9. +-ATPases: Aspects of the structure activity relationship and action mechanism. Life Sci., 45: 1111-1117.
10. Kokko, J.P., 1984. Site and Mechanism of action of diuretics. Am. J. Med., 77: 11-17.
11. Komiya, I., T. Yamada, N. Takasu, T. Asawa, H. Akamine, N. Yagi, Y. Nagasawa, H. Ohtsuka, Y. Miyahara, H. Sakai, H. Sato and T. Aizawa, 1997. Abnormal Sodium Metabolism in Japanese Patients with Essential Hypertension, Judged by Serum Sodium Distribution, Renal Function and the Renin-Aldosterone System. J. Hypertens., 15: 65-72.
12. Luscher, T.F., P.M. Vanhoutte and L. Raij, 1987. Antihypertensive treatment normalizes decreased endothelium-dependent relaxation in rats with salt-induced hypertension. Hypertension [suppl. III], 111: 193-197.
13. Middleton, R. Jr., C. Kandaswami and T.C. Theoharides, 2000. The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease and Cancer. Pharmacol. Rev., 52: 673-751.
14. Ogundaini, A.O., 2005. From Greens Into Medicine: Taking a Lead From Nature. An Inaugural Lecture Delivered at Oduduwa Hall, Obafemi Awolowo University, Ile-Ife, Nigeria. Inaugural Lecture Series 176. OAU Press Limited, Ile-Ife, Nigeria, pp: 12-15.
15. Oladunmoye, M.K., 2006. Comparative Evaluation of Antimicrobial Activities and Phytochemical Screening of Two Varieties of Acalypha wilkesiana. Trends in Appl. Sci. Res., 1: 538-541.
16. Rang, H.P., M.M. Dale, J.M. Ritter and P.K. Moore, 2005. Pharmacology. 5th Edn. Elsevier, India, pp: 300, 362-365.
17. +-ATPase inhibitors with potential cardiovascular activity. Drug Dev. Res., 46: 235-249.
18. + channels in the quercetin-induced inhibition of neuroblastoma cell growth. Pfluegers Arch., 423: 202-205.